Advertisement
Screener

Solid Biosciences Inc. (SLDB) Scorecard

2.8 / 5 stars · 68/120 Roast Me

Solid Biosciences Inc. (SLDB) Scorecard

  • 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
40 QUARTERS × 3 ROAST BATTLES
14/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q21/3 WinSLDB / S&P
38.75% / 15.20% 		LoseSLDB / S&P
SLDB unavailable / 15.00% 		LoseSLDB / S&P
-32.27% / 50.40%
2026-Q11/3 WinSLDB / S&P
27.66% / -4.33% 		LoseSLDB / S&P
SLDB unavailable / 11.30% 		LoseSLDB / S&P
-35.22% / 27.70%
2025-Q40/3 LoseSLDB / S&P
-8.59% / 2.65% 		LoseSLDB / S&P
SLDB unavailable / 9.00% 		LoseSLDB / S&P
-33.99% / 13.40%
2025-Q31/3 WinSLDB / S&P
26.69% / 8.12% 		LoseSLDB / S&P
SLDB unavailable / 4.61% 		LoseSLDB / S&P
-17.43% / 13.45%
2025-Q21/3 WinSLDB / S&P
31.62% / 10.94% 		LoseSLDB / S&P
SLDB unavailable / 4.83% 		LoseSLDB / S&P
-14.55% / 10.63%
2025-Q10/3 LoseSLDB / S&P
-7.50% / -4.27% 		LoseSLDB / S&P
SLDB unavailable / 4.98% 		LoseSLDB / S&P
-23.60% / 10.57%
2024-Q40/3 LoseSLDB / S&P
-42.61% / 2.41% 		LoseSLDB / S&P
SLDB unavailable / 5.25% 		LoseSLDB / S&P
-36.78% / 6.15%
2024-Q31/3 WinSLDB / S&P
22.93% / 5.89% 		LoseSLDB / S&P
SLDB unavailable / 5.89% 		LoseSLDB / S&P
-32.74% / 6.11%
2024-Q20/3 LoseSLDB / S&P
-57.43% / 4.28% 		LoseSLDB / S&P
SLDB unavailable / 5.38% 		LoseSLDB / S&P
-46.60% / 5.12%
2024-Q11/3 WinSLDB / S&P
116.94% / 10.56% 		LoseSLDB / S&P
SLDB unavailable / 5.71% 		LoseSLDB / S&P
-52.30% / 5.59%
2023-Q41/3 WinSLDB / S&P
143.65% / 11.69% 		LoseSLDB / S&P
SLDB unavailable / 6.81% 		LoseSLDB / S&P
-52.03% / 7.78%
2023-Q30/3 LoseSLDB / S&P
-51.91% / -3.27% 		LoseSLDB / S&P
SLDB unavailable / 7.52% 		LoseSLDB / S&P
-61.92% / -5.03%
2023-Q21/3 WinSLDB / S&P
10.55% / 8.74% 		LoseSLDB / S&P
SLDB unavailable / 9.50% 		LoseSLDB / S&P
-46.54% / -8.57%
2023-Q11/3 LoseSLDB / S&P
-11.90% / 7.50% 		LoseSLDB / S&P
SLDB unavailable / 10.77% 		WinSLDB / S&P
-1.67% / -15.69%
2022-Q40/3 LoseSLDB / S&P
-23.20% / 7.56% 		LoseSLDB / S&P
SLDB unavailable / 11.88% 		LoseSLDB / S&P
SLDB unavailable / -17.99%
2022-Q30/3 LoseSLDB / S&P
-24.19% / -4.88% 		LoseSLDB / S&P
SLDB unavailable / 13.47% 		LoseSLDB / S&P
SLDB unavailable / -1.41%
2022-Q20/3 LoseSLDB / S&P
-48.67% / -16.10% 		LoseSLDB / S&P
SLDB unavailable / 13.71% 		LoseSLDB / S&P
SLDB unavailable / 11.04%
2022-Q10/3 LoseSLDB / S&P
-31.43% / -4.60% 		LoseSLDB / S&P
SLDB unavailable / 15.97% 		LoseSLDB / S&P
SLDB unavailable / 42.23%
2021-Q40/3 LoseSLDB / S&P
-26.78% / 11.03% 		LoseSLDB / S&P
SLDB unavailable / 15.00% 		LoseSLDB / S&P
SLDB unavailable / 96.40%
2021-Q30/3 LoseSLDB / S&P
-34.70% / 0.58% 		LoseSLDB / S&P
SLDB unavailable / 10.77% 		LoseSLDB / S&P
SLDB unavailable / 69.42%
2021-Q20/3 LoseSLDB / S&P
-33.82% / 8.55% 		LoseSLDB / S&P
SLDB unavailable / 6.58% 		LoseSLDB / S&P
SLDB unavailable / 51.81%
2021-Q10/3 LoseSLDB / S&P
-27.04% / 6.17% 		LoseSLDB / S&P
SLDB unavailable / -1.06% 		LoseSLDB / S&P
SLDB unavailable / 7.39%
2020-Q41/3 WinSLDB / S&P
273.40% / 12.15% 		LoseSLDB / S&P
SLDB unavailable / -3.72% 		LoseSLDB / S&P
SLDB unavailable / -33.42%
2020-Q30/3 LoseSLDB / S&P
-30.72% / 8.93% 		LoseSLDB / S&P
SLDB unavailable / -2.04% 		LoseSLDB / S&P
SLDB unavailable / -27.10%
2020-Q21/3 WinSLDB / S&P
22.59% / 20.54% 		LoseSLDB / S&P
SLDB unavailable / -0.46% 		LoseSLDB / S&P
SLDB unavailable / -27.11%
2020-Q10/3 LoseSLDB / S&P
-46.29% / -19.60% 		LoseSLDB / S&P
SLDB unavailable / 3.47% 		LoseSLDB / S&P
SLDB unavailable / -14.75%
2019-Q40/3 LoseSLDB / S&P
-56.96% / 9.07% 		LoseSLDB / S&P
SLDB unavailable / 5.36% 		LoseSLDB / S&P
SLDB unavailable / 2.99%
2019-Q31/3 WinSLDB / S&P
79.83% / 1.70% 		LoseSLDB / S&P
SLDB unavailable / 5.02% 		LoseSLDB / S&P
SLDB unavailable / 0.21%
2019-Q20/3 LoseSLDB / S&P
-37.50% / 4.30% 		LoseSLDB / S&P
SLDB unavailable / 6.64% 		LoseSLDB / S&P
SLDB unavailable / 8.65%
2019-Q10/3 LoseSLDB / S&P
-65.67% / 13.65% 		LoseSLDB / S&P
SLDB unavailable / 8.12% 		LoseSLDB / S&P
SLDB unavailable / 14.29%
2018-Q40/3 LoseSLDB / S&P
-43.20% / -13.52% 		LoseSLDB / S&P
SLDB unavailable / 9.05% 		LoseSLDB / S&P
SLDB unavailable / 18.23%
2018-Q31/3 WinSLDB / S&P
32.42% / 7.71% 		LoseSLDB / S&P
SLDB unavailable / 10.21% 		LoseSLDB / S&P
SLDB unavailable / 19.06%
2018-Q21/3 WinSLDB / S&P
375.07% / 3.43% 		LoseSLDB / S&P
SLDB unavailable / 9.03% 		LoseSLDB / S&P
SLDB unavailable / 14.46%
2018-Q10/3 LoseSLDB / S&P
SLDB unavailable / -0.76% 		LoseSLDB / S&P
SLDB unavailable / 7.68% 		LoseSLDB / S&P
SLDB unavailable / 12.46%
2017-Q40/3 LoseSLDB / S&P
SLDB unavailable / 6.64% 		LoseSLDB / S&P
SLDB unavailable / 7.03% 		LoseSLDB / S&P
SLDB unavailable / 13.82%
2017-Q30/3 LoseSLDB / S&P
SLDB unavailable / 4.48% 		LoseSLDB / S&P
SLDB unavailable / 5.68% 		LoseSLDB / S&P
SLDB unavailable / 17.57%
2017-Q20/3 LoseSLDB / S&P
SLDB unavailable / 3.09% 		LoseSLDB / S&P
SLDB unavailable / 4.83% 		LoseSLDB / S&P
SLDB unavailable / 17.74%
2017-Q10/3 LoseSLDB / S&P
SLDB unavailable / 6.07% 		LoseSLDB / S&P
SLDB unavailable / 3.67% 		LoseSLDB / S&P
SLDB unavailable / 13.32%
2016-Q40/3 LoseSLDB / S&P
SLDB unavailable / 3.82% 		LoseSLDB / S&P
SLDB unavailable / 2.09% 		LoseSLDB / S&P
SLDB unavailable / 7.05%
2016-Q30/3 LoseSLDB / S&P
SLDB unavailable / 3.85% 		LoseSLDB / S&P
SLDB unavailable / 0.20% 		LoseSLDB / S&P
SLDB unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricSLDB total returnS&P 500 Total Return Index
Total return84.85%20.78%
Annualized return84.85%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricSLDB total returnS&P 500 Total Return Index
Total return-75.44%83.14%
Annualized return-24.48%12.86%

10Y · 2018-01-26 to 2026-08-27

MetricSLDB total returnS&P 500 Total Return Index
Total return-97.01%319.30%
Annualized return-29.61%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Advertisement